Basic Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jun 28, 2020; 26(24): 3432-3446
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3432
Figure 4
Figure 4 Complex interaction network between targets, the eligible ingredients, and alcoholic liver disease. A: Perlolyrine; B: β-sitosterol; C: Kaempferol; D: Naringenin; E: Stigmasterol; F: Quercetin. ALD: Alcoholic liver disease; H. dulcis: Hovenia dulcis.